1.A Case of Adult Polyglucosan Body Disease.
Seung Yeob LEE ; Jae Hyeon PARK ; So Hun KIM ; Tai Seung KIM ; Won Joo KIM ; Young Chul CHOI
Yonsei Medical Journal 2007;48(4):701-703
Adult polyglucosan body disease (APBD) is a rare neurological disease, characterized by adult onset (fifth to seventh decades), progressive sensorimotor or pure motor peripheral neuropathy, upper motor neuron symptoms, neurogenic bladder, and cognitive impairment. APBD is confirmed by a sural nerve biopsy that shows the widespread presence of polyglucosan bodies in the nerve. We report a 70 year old male patient who exhibited progressive weakness in all extremities and dementia. His electrodiagnostic studies showed sensorimotor polyneuropathy and muscle pathology that consisted of polyglucosan bodies located in small peripheral nerves. This is the first case of APBD reported in Korea.
Aged
;
Biopsy
;
*Glucans/metabolism
;
Humans
;
Inclusion Bodies
;
Male
;
Neurodegenerative Diseases/metabolism/*pathology
2.Advances of researches on caspases in neurodegenerative diseases.
Hongyu XUE ; Xuemei FANG ; Weiwei WANG ; Guizhen GAO
Journal of Biomedical Engineering 2013;30(2):438-442
Acute and chronic neurodegenerative diseases are illnesses associated with high morbidity and mortality, and few or no effective options are available for their treatments. Many neurodegenerative diseases are included in them, for example, stroke, brain trauma, spinal cord injury, amyotrophic lateral sclerosis (ALS), Huntington's disease, Alzheimer's disease, and Parkinson's disease. Given that central nervous system tissue has very limited, if any, regenerative capacity, it is of utmost importance to limit the damage caused by neuronal death. During the past decade, considerable progress has been made in understanding the process of cell death. In this article, we review the causes and mechanisms of neuronal-cell death, especially as it pertains to the caspases family of proteases associated with cell death. The results may be helpful to the experimental research and clinical application of neurodegenerative diseases.
Animals
;
Apoptosis
;
physiology
;
Caspases
;
metabolism
;
Cell Death
;
Humans
;
Neurodegenerative Diseases
;
enzymology
;
pathology
;
Neurons
;
pathology
;
Peptide Hydrolases
;
metabolism
3.Neuronal autophagy and neurodegenerative diseases.
Jin H SON ; Jung Hee SHIM ; Kyung Hee KIM ; Ji Young HA ; Ji Young HAN
Experimental & Molecular Medicine 2012;44(2):89-98
Autophagy is a dynamic cellular pathway involved in the turnover of proteins, protein complexes, and organelles through lysosomal degradation. The integrity of postmitotic neurons is heavily dependent on high basal autophagy compared to non-neuronal cells as misfolded proteins and damaged organelles cannot be diluted through cell division. Moreover, neurons contain the specialized structures for intercellular communication, such as axons, dendrites and synapses, which require the reciprocal transport of proteins, organelles and autophagosomes over significant distances from the soma. Defects in autophagy affect the intercellular communication and subsequently, contributing to neurodegeneration. The presence of abnormal autophagic activity is frequently observed in selective neuronal populations afflicted in common neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis. These observations have provoked controversy regarding whether the increase in autophagosomes observed in the degenerating neurons play a protective role or instead contribute to pathogenic neuronal cell death. It is still unknown what factors may determine whether active autophagy is beneficial or pathogenic during neurodegeneration. In this review, we consider both the normal and pathophysiological roles of neuronal autophagy and its potential therapeutic implications for common neurodegenerative diseases.
Alzheimer Disease/metabolism/pathology/physiopathology
;
Animals
;
Autophagy/*physiology
;
Humans
;
Huntington Disease/metabolism/pathology/physiopathology
;
Models, Biological
;
Neurodegenerative Diseases/metabolism/*pathology/physiopathology
;
Neurons/*cytology
;
Parkinson Disease/metabolism/pathology/physiopathology
4.Factors Influencing Alzheimer's Disease Risk: Whether and How They are Related to the APOE Genotype.
Rong ZHANG ; Xiaojiao XU ; Hang YU ; Xiaolan XU ; Manli WANG ; Weidong LE
Neuroscience Bulletin 2022;38(7):809-819
Alzheimer's disease (AD) is the most prevalent neurodegenerative disease featuring progressive cognitive impairment. Although the etiology of late-onset AD remains unclear, the close association of AD with apolipoprotein E (APOE), a gene that mainly regulates lipid metabolism, has been firmly established and may shed light on the exploration of AD pathogenesis and therapy. However, various confounding factors interfere with the APOE-related AD risk, raising questions about our comprehension of the clinical findings concerning APOE. In this review, we summarize the most debated factors interacting with the APOE genotype and AD pathogenesis, depict the extent to which these factors relate to APOE-dependent AD risk, and discuss the possible underlying mechanisms.
Alzheimer Disease/pathology*
;
Apolipoprotein E4/genetics*
;
Apolipoproteins E/genetics*
;
Genotype
;
Humans
;
Lipid Metabolism
;
Neurodegenerative Diseases
;
Risk Factors
5.Histopathological and immunohistochemical study of spinal cord tissues in neurodegenerative diseases.
Mingwei ZHU ; Luning WANG ; Jia LIU ; Qiuping GUI ; Yanjun GUO ; Yazhuo HU ; Honghong ZHANG
Chinese Journal of Pathology 2015;44(8):587-593
OBJECTIVETo investigate histopathology and proteinopathy in the spinal cord of patients with common neurodegenerative diseases.
METHODSSpinal cord tissues from clinically and neuropathologically confirmed neruodegnerative diseases were enrolled in this study, including 3 cases of multiple system strophy, 4 cases of amyotrophic lateral sclerosis, 5 cases of Alzheimer's disease (AD, included 2 cases of AD combined with Parkinson's disease), 2 cases of progressive supranuclear palsy, 1 case of dementia with lewy body and 1 case of corticobasal degeneration from 1955 to 2013 at Chinese People's Liberation Army General Hospital. Four normal control cases were also included. Routine HE and Gallyas-Braak staining, and immunohistochemical stainings for anti-PHF tau (AT8), anti-α-synuclein, anti-TDP-43 and anti-ubiquitin were performed.
RESULTSExamination of the spinal cord in 3 cases with multiple system strophy revealed severe neuron loss in the intermediolateral nucleus of thoracic segment and Onuf's nucleus of the sacral segment, along with moderate neuron loss in the anterior horn of the cervical segment and mild myelin pallor in the anterior funiculus and anterolateral funiculus in the cervical and thoracic segments. Large amount of argentophilic, ubiquitin and synuclein positive oligodendroglial cytoplasmic inclusions were found widely distributed in the anterior horn and the anterior funiculus and anterolateral funiculus of the full spinal cord. Severe neuron loss and several morphological changes with gliosis in the anterior horn and severe loss of myelin in the anterior funiculus and anterolateral funiculus of the full spinal cord were observed in 4 cases of amyotrophic lateral sclerosis, 2 of which were found with Bunina bodies in neurons of the anterior horn. Three amyotrophic lateral sclerosis cases had ubiquitin-positive neuronal inclusions and TDP-43 positive neuronal and glial inclusions in the anterior horn at cervical and lumbar segments. A few argentophilic, tau positive neurofibrillary tangles (NFTs) and neuropil threads in the anterior horn at cervical and lumbar segments were found in 4 AD cases. Examination of spinal cord in 2 cases with Parkinson's disease combined with AD and 1 case with dementia with lewy body revealed severe neuron loss in the intermediolateral nucleus of thoracic segment, and a few synuclein positive lewy bodies and neuritis were also observed. There was mild neuron loss in the anterior horn at cervical and lumbar segments, along with some argentophilic, tau positive globous NFTs and many argentophilic, tau positive neutrophil threads were observed in 2 progressive supranuclear palsy cases and 1 corticobasal degeneration case.
CONCLUSIONEach common neurodegenerative diseases of the spinal cord including multiple system strophy, amyotrophic lateral sclerosis and Parkinson's disease has its own specific histopathology and proteinopathy characteristics.
Alzheimer Disease ; pathology ; Amyotrophic Lateral Sclerosis ; pathology ; DNA-Binding Proteins ; metabolism ; Humans ; Immunohistochemistry ; Inclusion Bodies ; pathology ; Neurodegenerative Diseases ; pathology ; Neurofibrillary Tangles ; pathology ; Neurons ; pathology ; Parkinson Disease ; pathology ; Spinal Cord ; pathology ; Ubiquitin ; metabolism ; alpha-Synuclein ; metabolism
6.Neural stem cells: mechanisms and modeling.
Jun YAO ; Yangling MU ; Fred H GAGE
Protein & Cell 2012;3(4):251-261
In the adult brain, neural stem cells have been found in two major niches: the dentate gyrus and the subventricular zone [corrected]. Neurons derived from these stem cells contribute to learning, memory, and the autonomous repair of the brain under pathological conditions. Hence, the physiology of adult neural stem cells has become a significant component of research on synaptic plasticity and neuronal disorders. In addition, the recently developed induced pluripotent stem cell technique provides a powerful tool for researchers engaged in the pathological and pharmacological study of neuronal disorders. In this review, we briefly summarize the research progress in neural stem cells in the adult brain and in the neuropathological application of the induced pluripotent stem cell technique.
Hippocampus
;
cytology
;
metabolism
;
Humans
;
Induced Pluripotent Stem Cells
;
cytology
;
metabolism
;
Models, Biological
;
Neural Stem Cells
;
cytology
;
metabolism
;
transplantation
;
Neurodegenerative Diseases
;
metabolism
;
pathology
;
prevention & control
;
Neurogenesis
;
Signal Transduction
7.Bear bile powder alleviates Parkinson's disease-like behavior in mice by inhibiting astrocyte-mediated neuroinflammation.
Lupeng WANG ; Yuyan BAI ; Yanlin TAO ; Wei SHEN ; Houyuan ZHOU ; Yixin HE ; Hui WU ; Fei HUANG ; Hailian SHI ; Xiaojun WU
Chinese Journal of Natural Medicines (English Ed.) 2023;21(9):710-720
Parkinson's disease (PD) is a common neurodegenerative disease in middle-aged and elderly people. In particular, increasing evidence has showed that astrocyte-mediated neuroinflammation is involved in the pathogenesis of PD. As a precious traditional Chinese medicine, bear bile powder (BBP) has a long history of use in clinical practice. It has numerous activities, such as clearing heat, calming the liver wind and anti-inflammation, and also exhibits good therapeutic effect on convulsive epilepsy. However, whether BBP can prevent the development of PD has not been elucidated. Hence, this study was designed to explore the effect and mechanism of BBP on suppressing astrocyte-mediated neuroinflammation in a mouse model of PD. PD-like behavior was induced in the mice by intraperitoneal injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (30 mg·kg-1) for five days, followed by BBP (50, 100, and 200 mg·kg-1) treatment daily for ten days. LPS stimulated rat C6 astrocytic cells were used as a cell model of neuroinflammation. THe results indicated that BBP treatment significantly ameliorated dyskinesia, increased the levels of tyrosine hydroxylase (TH) and inhibited astrocyte hyperactivation in the substantia nigra (SN) of PD mice. Furthermore, BBP decreased the protein levels of glial fibrillary acidic protein (GFAP), cyclooxygenase 2 (COX2) and inducible nitric oxide synthase (iNOS), and up-regulated the protein levels of takeda G protein-coupled receptor 5 (TGR5) in the SN. Moreover, BBP significantly activated TGR5 in a dose-dependent manner, and decreased the protein levels of GFAP, iNOS and COX2, as well as the mRNA levels of GFAP, iNOS, COX2, interleukin (IL) -1β, IL-6 and tumor necrosis factor-α (TNF-α) in LPS-stimulated C6 cells. Notably, BBP suppressed the phosphorylation of protein kinase B (AKT), inhibitor of NF-κB (IκBα) and nuclear factor-κB (NF-κB) proteins in vivo and in vitro. We also observed that TGR5 inhibitor triamterene attenuated the anti-neuroinflammatory effect of BBP on LPS-stimulated C6 cells. Taken together, BBP alleviates the progression of PD mice by suppressing astrocyte-mediated inflammation via TGR5.
Humans
;
Mice
;
Rats
;
Animals
;
Aged
;
Middle Aged
;
Parkinson Disease/pathology*
;
Astrocytes/pathology*
;
Powders/therapeutic use*
;
Ursidae/metabolism*
;
NF-kappa B/metabolism*
;
Neuroinflammatory Diseases
;
Neurodegenerative Diseases/metabolism*
;
Cyclooxygenase 2/metabolism*
;
Lipopolysaccharides/pharmacology*
;
Bile
;
Mice, Inbred C57BL
;
Microglia
;
Disease Models, Animal
8.Cellular model of neuronal atrophy induced by DYNC1I1 deficiency reveals protective roles of RAS-RAF-MEK signaling.
Zhi-Dong LIU ; Su ZHANG ; Jian-Jin HAO ; Tao-Rong XIE ; Jian-Sheng KANG
Protein & Cell 2016;7(9):638-650
Neuronal atrophy is a common pathological feature occurred in aging and neurodegenerative diseases. A variety of abnormalities including motor protein malfunction and mitochondrial dysfunction contribute to the loss of neuronal architecture; however, less is known about the intracellular signaling pathways that can protect against or delay this pathogenic process. Here, we show that the DYNC1I1 deficiency, a neuron-specific dynein intermediate chain, causes neuronal atrophy in primary hippocampal neurons. With this cellular model, we are able to find that activation of RAS-RAF-MEK signaling protects against neuronal atrophy induced by DYNC1I1 deficiency, which relies on MEK-dependent autophagy in neuron. Moreover, we further reveal that BRAF also protects against neuronal atrophy induced by mitochondrial impairment. These findings demonstrate protective roles of the RAS-RAF-MEK axis against neuronal atrophy, and imply a new therapeutic target for clinical intervention.
Animals
;
Cell Line
;
Cytoplasmic Dyneins
;
genetics
;
metabolism
;
Hippocampus
;
metabolism
;
pathology
;
MAP Kinase Kinase Kinases
;
genetics
;
metabolism
;
MAP Kinase Signaling System
;
Mice
;
Mice, Knockout
;
Neurodegenerative Diseases
;
genetics
;
metabolism
;
pathology
;
Proto-Oncogene Proteins B-raf
;
genetics
;
metabolism
;
ras Proteins
;
genetics
;
metabolism
9.The roles of the proteasome pathway in signal transduction and neurodegenerative diseases.
Jiao-Jiao CHEN ; Fang LIN ; Zheng-Hong QIN
Neuroscience Bulletin 2008;24(3):183-194
There are two degradation systems in mammalian cells, autophagy/lysosomal pathway and ubiquitin-proteasome pathway. Proteasome is consist of multiple protein subunits and plays important roles in degradation of short-lived cellular proteins. Recent studies reveal that proteasomal degradation system is also involved in signal transduction and regulation of various cellular functions. Dysfunction or dysregulation of proteasomal function may thus be an important pathogenic mechanism in certain neurological disorders. This paper reviews the biological functions of proteasome in signal transduction and its potential roles in neurodegenerative diseases.
Animals
;
Brain
;
metabolism
;
physiopathology
;
Humans
;
Inclusion Bodies
;
metabolism
;
pathology
;
Nerve Tissue Proteins
;
metabolism
;
Neurodegenerative Diseases
;
metabolism
;
physiopathology
;
Proteasome Endopeptidase Complex
;
metabolism
;
Protein Folding
;
Signal Transduction
;
physiology
;
Ubiquitin-Protein Ligases
;
metabolism
;
Ubiquitination
;
physiology
10.Effects and Mechanisms of Taurine as a Therapeutic Agent.
Biomolecules & Therapeutics 2018;26(3):225-241
Taurine is an abundant, β-amino acid with diverse cytoprotective activity. In some species, taurine is an essential nutrient but in man it is considered a semi-essential nutrient, although cells lacking taurine show major pathology. These findings have spurred interest in the potential use of taurine as a therapeutic agent. The discovery that taurine is an effective therapy against congestive heart failure led to the study of taurine as a therapeutic agent against other disease conditions. Today, taurine has been approved for the treatment of congestive heart failure in Japan and shows promise in the treatment of several other diseases. The present review summarizes studies supporting a role of taurine in the treatment of diseases of muscle, the central nervous system, and the cardiovascular system. In addition, taurine is extremely effective in the treatment of the mitochondrial disease, mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), and offers a new approach for the treatment of metabolic diseases, such as diabetes, and inflammatory diseases, such as arthritis. The review also addresses the functions of taurine (regulation of antioxidation, energy metabolism, gene expression, ER stress, neuromodulation, quality control and calcium homeostasis) underlying these therapeutic actions.
Acidosis, Lactic
;
Arthritis
;
Brain Diseases
;
Calcium
;
Cardiovascular System
;
Central Nervous System
;
Cytoprotection
;
Energy Metabolism
;
Gene Expression
;
Heart Failure
;
Japan
;
MELAS Syndrome
;
Metabolic Diseases
;
Mitochondrial Diseases
;
Neurodegenerative Diseases
;
Pathology
;
Quality Control
;
Taurine*